Keywords: Novo Nordisk, Victoza, FDA approval, Type 2 diabetes, Sales potential

FDA approves Novo Nordisk’s new type 2 diabetes drug Victoza

Article | 26 January 2010

Print This

The US Food and Drug Administration yesterday approved Danish insulin giant Novo Nordisk’s Victoza (liraglutide), a once-daily injection ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in